China Anatomic Pathology Market Size & Outlook, 2026-2033
The anatomic pathology market in China is expected to reach a projected revenue of US$ 4,994.5 million by 2033. A compound annual growth rate of 12.4% is expected of China anatomic pathology market from 2026 to 2033.
- Clinical Diagnostics
- Tissue Diagnostics
- Anatomic Pathology Market Outlook
- Tissue Diagnostics
Revenue, 2025 (US$M)
$1,969.7
Estimate, 2026 (US$M)
$2,200.3
Forecast, 2033 (US$M)
$4,994.5
CAGR, 2026 - 2033
12.4%
Global Market
Related Markets
GVR research-powered AI
Ask Prism AI about the anatomic pathology market
Get cited answers from GVR research on market growth, segments, regulations and forecasts.
- Source-linked answers
- Market-specific context
- Traceable figures
China anatomic pathology market highlights
- The China anatomic pathology market generated a revenue of USD 1,969.7 million in 2025 and is expected to reach USD 4,994.5 million by 2033.
- The China market is expected to grow at a CAGR of 12.4% from 2026 to 2033.
- In terms of segment, reagents & consumables was the largest revenue generating product & services in 2025.
- Reagents & Consumables is the most lucrative product & services segment registering the fastest growth during the forecast period.
Anatomic pathology market data book summary
| Market revenue in 2025 | USD 1,969.7 million |
| Market revenue in 2033 | USD 4,994.5 million |
| Growth rate | 12.4% (CAGR from 2026 to 2033) |
| Largest segment | Reagents & consumables |
| Fastest growing segment | Reagents & Consumables |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Others Products & Services |
| Key market players worldwide | Danaher Corp, PHC Holdings Corp, Quest Diagnostics Inc, Labcorp Holdings Inc, Roche Holding AG ADR, Agilent Technologies Inc, Cardinal Health Inc, Sakura Finetek USA, Inc., NeoGenomics, Biogenex, Bio SB, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, China accounted for 5.1% of the global anatomic pathology market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China anatomic pathology market is projected to lead the regional market in terms of revenue in 2033.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 3,799.8 million by 2033.
No credit card required*
Publish Date: May 20, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Anatomic Pathology Market Scope
Anatomic Pathology Market segmentation & scope
Anatomic Pathology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Danaher Corp | View profile | 63,000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | www.danaher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Cardinal Health Inc | View profile | 48,000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | www.cardinalhealth.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| PHC Holdings Corp | View profile | 11,897 | 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo, Japan, 105-8433 | www.phchd.com |
| Sakura Finetek USA, Inc. | View profile | 101-250 | Torrance, California, United States, North America | sakuraus.com |
| NeoGenomics | View profile | 501-1000 | Fort Myers, Florida, United States, North America | www.neogenomics.com |
China Anatomic Pathology Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Anatomic Pathology Market Outlook will help companies and investors design strategic landscapes.
Reagents & Consumables was the largest segment with a revenue share of 54.19% in 2025.
Horizon Databook has segmented the China anatomic pathology market based on instruments, reagents & consumables, others products & services covering the revenue growth of each sub-segment from 2021 to 2033.
- China Anatomic Pathology Market Product & Services Outlook (Revenue, USD Million , 2021-2033)
- Instruments
- Reagents & Consumables
- Others Products & Services
- China Anatomic Pathology Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Histopathology
- Cytopathology
- Immunohistochemistry (IHC)
- In Situ Hybridization (ISH)
- Digital Pathology
- Molecular Pathology
- AI-enabled Pathology
- China Anatomic Pathology Market Application Outlook (Revenue, USD Million , 2021-2033)
- Disease Diagnosis
- Drug Discovery & Development
- Others Application
- China Anatomic Pathology Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
Reasons to subscribe to Anatomic Pathology Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Anatomic Pathology Market Outlook databook
- Our clientele includes a mix of Anatomic Pathology Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China Anatomic Pathology Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into China Anatomic Pathology Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
China Anatomic Pathology Market, 2021-2033 (US$M)
China anatomic pathology market statistics, by product & services, 2021-2033 (US$M)
